|
???tair.name??? >
???browser.page.title.author???
|
"tseng jeng sen"???jsp.browse.items-by-author.description???
Showing items 51-56 of 56 (3 Page(s) Totally) << < 1 2 3 View [10|25|50] records per page
國立臺灣大學 |
2015 |
Identification of Five Driver Gene Mutations in Patients with Treatment-Naive Lung Adenocarcinoma in Taiwan
|
Hsu, Kuo-Hsuan; Ho, Chao-Chi; Hsia, Te-Chun; Tseng, Jeng-Sen; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Yang, Tsung-Ying; Chen, Kun-Chieh; Ooi, Hean; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Chang, Gee-Chen; 俞松良; 蘇剛毅; 楊泮池; 廖唯昱; 陳冠宇; 余忠仁; 何肇基; 施金元 |
國立臺灣大學 |
2015 |
Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chang, Gee-Chen; 俞松良; 蘇剛毅 |
國立臺灣大學 |
2015 |
R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability
|
Chen, Hsuan-Yu; Yu, Sung-Liang; Ho, Bing-Ching; Su, Kang-Yi; Hsu, Yi-Chiung; Chang, Chi-Sheng; Li, Yu-Cheng; Yang, Shi-Yi; Hsu, Pin-Yen; Ho, Hao; Chang, Ya-Hsuan; Chen, Chih-Yi; Yang, Hwai-I; Hsu, Chung-Ping; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Yuan, Shinsheng; Lee, Mei-Hsuan; Liu, Chia-Hsin; Wu, Guan-I; Hsiung, Chao A.; Chen, Yuh-Min; Wang, Chih-Liang; Huang, Ming-Shyan; Yu, Chong-Jen; Chen, Kuan-Yu; Tsai, Ying-Huang; Su, Wu-Chou; Chen, Huei-Wen; Chen, Jeremy J. W.; Chen, Chien-Jen; Chang, Gee-Chen; Yang, Pan-Chyr; Li, Ker-Chau; 俞松良; 蘇剛毅; 楊泮池; 陳冠宇; 余忠仁; 陳惠文 |
臺北醫學大學 |
2014 |
Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
|
Tseng, Jeng-Sen;Wang, Chih-Liang;Huang, Ming-Shyan;Chen, Chung-Yu;Chang, Cheng-Yu;Yang, Tsung-Ying;Tsai, Chi-Ren;Chen, Kun-Chieh;Hsu, Kuo-Hsuan;Tsai, Meen-Hsin;Yu, Sung-Liang;Su, Kang-Yi;Wu, Chih-Wei;Yang, Cheng-Ta;Chen, Yuh-Min;Chang, Gee-Chen |
國立臺灣大學 |
2014 |
Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaive patients with EGFR-mutant lung adenocarcinoma
|
Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Hsuan-Yu; Chang, Gee-Chen; 俞松良; 蘇剛毅; 廖唯昱; 余忠仁 |
國立臺灣大學 |
2014 |
Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
|
Tseng, Jeng-Sen; Wang, Chih-Liang; Huang, Ming-Shyan; Chen, Chung-Yu; Chang, Cheng-Yu; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; Yu, Sung-Liang; Su, Kang-Yi; Wu, Chih-Wei; Yang, Cheng-Ta; Chen, Yuh-Min; Chang, Gee-Chen; 俞松良; 蘇剛毅; 陳崇裕 |
Showing items 51-56 of 56 (3 Page(s) Totally) << < 1 2 3 View [10|25|50] records per page
|